Eric Cleveland Bigham

Title: The Innovations of Eric Cleveland Bigham

Introduction

Eric Cleveland Bigham, an accomplished inventor based in Durham, NC, has made significant contributions to the field of pharmaceuticals. With a strong background in medicinal chemistry, he has focused his research efforts on compounds that can aid in treating critical health issues.

Latest Patents

Bigham holds a patent for "Imidazoline derivatives as alpha-1A adrenoceptor ligands." The patent describes a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof. These compounds are particularly useful in the treatment of Alpha-1A mediated diseases, including urinary incontinence, reflecting Bigham's commitment to developing novel therapeutic solutions.

Career Highlights

Eric Bigham has been affiliated with SmithKline Beecham Corporation, where he has played a pivotal role in advancing drug development. His tenure at the company has enabled him to collaborate with fellow scientists while contributing to the innovation of medicinal therapies.

Collaborations

Throughout his career, Bigham has worked closely with esteemed colleagues such as Michael Joseph Bishop and David Harold Drewry. Their collaborative efforts have fostered an environment of creativity and innovation, which has led to advancements in the field of pharmaceuticals.

Conclusion

In summary, Eric Cleveland Bigham's patent on Imidazoline derivatives is a testament to his innovative approach and expertise in medicinal chemistry. His ongoing work at SmithKline Beecham Corporation, coupled with his collaborations with notable scientists, ensures that he remains a significant figure in the realm of pharmaceutical inventions. Bigham’s contributions continue to pave the way for effective treatments and improved health outcomes.